|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
CN100444840C
(zh)
|
2003-05-15 |
2008-12-24 |
罗斯坎普研究有限公司 |
减少淀粉样沉积、淀粉样神经毒性和小胶质增生的药物
|
|
WO2005000288A2
(en)
*
|
2003-06-23 |
2005-01-06 |
Neurochem (International) Limited |
Treatment of protein aggregation disorders
|
|
US20070010573A1
(en)
|
2003-06-23 |
2007-01-11 |
Xianqi Kong |
Methods and compositions for treating amyloid-related diseases
|
|
US20050142191A1
(en)
*
|
2003-06-23 |
2005-06-30 |
Neurochem (International) Limited |
Pharmaceutical formulations of amyloid inhibiting compounds
|
|
CA2529257C
(en)
*
|
2003-06-23 |
2013-04-23 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
AU2011250847B2
(en)
*
|
2003-06-23 |
2013-06-20 |
Bhi Limited Partnership |
Methods and compositions for treating amyloid-related diseases
|
|
KR20110140139A
(ko)
*
|
2003-08-29 |
2011-12-30 |
오노 야꾸힝 고교 가부시키가이샤 |
Ｓ１ｐ 수용체 결합능을 갖는 화합물 및 그 의약 용도
|
|
AR047062A1
(es)
|
2003-12-17 |
2006-01-04 |
Wyeth Corp |
Conjugados portadores de peptidos inmunogenicos a beta y metodos para producirlos
|
|
MXPA06011969A
(es)
*
|
2004-04-14 |
2006-12-15 |
Warner Lambert Co |
Combinacion terapeutica para tratamiento de la enfermedad de alzheimer.
|
|
CA2582385A1
(en)
*
|
2004-06-18 |
2005-12-18 |
Neurochem (International) Limited |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
JP4717537B2
(ja)
*
|
2004-08-31 |
2011-07-06 |
株式会社 資生堂 |
皮膚外用組成物
|
|
EP1828111A2
(en)
*
|
2004-11-12 |
2007-09-05 |
Neurochem (International) Limited |
Methods and fluorinated compositions for treating amyloid-related diseases
|
|
JP5145537B2
(ja)
*
|
2004-12-22 |
2013-02-20 |
ビーエイチアイ リミテッド パートナーシップ |
アミロイド関連疾患を治療するための方法および組成物
|
|
TW200716088A
(en)
*
|
2005-04-15 |
2007-05-01 |
Neurochem Int Ltd |
Formulations and methods for treating amyloidosis
|
|
US7420071B2
(en)
*
|
2005-05-04 |
2008-09-02 |
Uchicago Argonne, Llc |
Thermally stable surfactants and compositions and methods of use thereof
|
|
CN117903302A
(zh)
|
2005-11-30 |
2024-04-19 |
Abbvie 公司 |
抗-Aβ球聚体抗体，其相关产品，生产所述抗体的方法，所述抗体的应用以及使用方法
|
|
PT1976877E
(pt)
|
2005-11-30 |
2014-04-29 |
Abbvie Inc |
Anticorpos monoclonais contra proteína beta-amilóide e suas utilizações
|
|
ES2454253T3
(es)
|
2005-12-12 |
2014-04-10 |
Ac Immune S.A. |
Anticuerpos monoclonales específicos de beta A 1-42 con propiedades terapéuticas
|
|
MY181173A
(en)
|
2005-12-12 |
2020-12-21 |
Ac Immune Sa |
Therapeutic vaccine
|
|
DE602006016990D1
(de)
|
2005-12-22 |
2010-10-28 |
Bellus Health Int Ltd |
Behandlung von diabetischer nephropathie
|
|
WO2007084818A2
(en)
*
|
2006-01-10 |
2007-07-26 |
Pipex, Inc. |
Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
|
|
KR101605207B1
(ko)
|
2006-07-14 |
2016-03-22 |
에이씨 이뮨 에스.에이. |
아밀로이드 베타에 대해 인간화된 항체
|
|
CN103524617B
(zh)
|
2006-07-14 |
2016-12-28 |
Ac免疫有限公司 |
针对淀粉状蛋白β的人源化抗体
|
|
JP5607930B2
(ja)
|
2006-10-12 |
2014-10-15 |
ビーエイチアイ リミテッド パートナーシップ |
３−アミノ−１−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
|
|
WO2008070284A2
(en)
|
2006-10-16 |
2008-06-12 |
Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute |
Amyloid beta peptides and methods of uses thereof
|
|
KR101450356B1
(ko)
|
2006-11-24 |
2014-10-15 |
에이씨 이뮨 에스.에이. |
알츠하이머와 같은 아밀로이드 또는 아밀로이드-유사 단백질과 관련된 질환의 치료를 위한 ｎ-(메틸)-1ｈ-피라졸-3-아민, ｎ-(메틸)-피리딘-2-아민 및 ｎ-(메틸)-티아졸-2-아민 유도체
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
GB0701970D0
(en)
*
|
2007-02-01 |
2007-03-14 |
Wilson Stuart |
Treatment of protein aggregation diseases
|
|
US20100311767A1
(en)
|
2007-02-27 |
2010-12-09 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
|
WO2008106657A2
(en)
*
|
2007-03-01 |
2008-09-04 |
Intezyne Technologies, Inc. |
Encapsulated amyloid-beta peptides
|
|
EP2160352A2
(en)
*
|
2007-05-24 |
2010-03-10 |
Simone Arca |
Method for the production of binary clathrate hydrates of hydrogen
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
AR066987A1
(es)
|
2007-06-12 |
2009-09-23 |
Ac Immune Sa |
Anticuerpo monoclonal contra proteina beta-amiloide
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
PL2170389T3
(pl)
|
2007-06-12 |
2015-03-31 |
Ac Immune Sa |
Humanizowane przeciwciało przeciw amyloidowi beta
|
|
AU2008280782B2
(en)
*
|
2007-07-20 |
2014-01-23 |
Diamedica Inc. |
Tissue kallikrein for the treatment of diseases associated with amyloid protein
|
|
EP2044951A1
(en)
|
2007-10-02 |
2009-04-08 |
Merz Pharma GmbH & Co. KGaA |
The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
|
|
RU2571859C2
(ru)
|
2007-10-05 |
2015-12-20 |
Дженентек, Инк. |
Применение антитела против амилоида-бета при глазных заболеваниях
|
|
ES2445590T3
(es)
|
2007-10-05 |
2014-03-04 |
Genentech, Inc. |
Uso de anticuerpo anti-amiloide beta en enfermedades oculares
|
|
BRPI0817516A2
(pt)
|
2007-10-05 |
2015-06-16 |
Alzheimer S Inst Of America Inc |
Método para reduzir deposição de amilóide, neurotoxicidade de amilóide e microgliose com o enantiômero de (-)-nilvadipino
|
|
WO2009059239A2
(en)
*
|
2007-11-02 |
2009-05-07 |
Mayo Foundation For Medical Education And Research |
REDUCING Aβ42 LEVELS AND Aβ AGGREGATION
|
|
EP2149380A1
(en)
*
|
2008-07-29 |
2010-02-03 |
Medivet Pharma, S.L. |
Veterinary immunotherapy compositions for the Aged Related Cognitive Dysfunction.
|
|
US8846315B2
(en)
|
2008-08-12 |
2014-09-30 |
Zinfandel Pharmaceuticals, Inc. |
Disease risk factors and methods of use
|
|
WO2010042603A1
(en)
*
|
2008-10-08 |
2010-04-15 |
Cingulate Neuro Therapeutics, Llc |
Amyloid and depression
|
|
PT2408807T
(pt)
|
2009-03-18 |
2021-09-03 |
Ac Immune Sa |
Processo para utilização terapêutica
|
|
UA107571C2
(xx)
|
2009-04-03 |
2015-01-26 |
|
Фармацевтична композиція
|
|
JP5051274B2
(ja)
|
2009-06-04 |
2012-10-17 |
住友化学株式会社 |
加硫ゴムが有する粘弾性特性を改善させるためのｓ−（３−アミノプロピル）チオ硫酸および／またはその金属塩の使用
|
|
EP2311823A1
(en)
|
2009-10-15 |
2011-04-20 |
AC Immune S.A. |
2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
|
|
CN104744591B
(zh)
|
2010-04-15 |
2022-09-27 |
Abbvie德国有限责任两合公司 |
β淀粉样蛋白结合蛋白
|
|
EP2377860A1
(en)
|
2010-04-16 |
2011-10-19 |
AC Immune S.A. |
Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
|
|
DK2558446T5
(da)
|
2010-04-16 |
2019-12-09 |
Ac Immune Sa |
Nye forbindelser til behandling af sygdomme associerede med amyloid- eller amyloidlignende proteiner
|
|
US9221900B2
(en)
|
2010-07-30 |
2015-12-29 |
Ac Immune S.A. |
Methods for identifying safe and functional humanized antibodies
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
HUE027649T2
(en)
|
2010-10-07 |
2016-10-28 |
Ac Immune Sa |
Antibodies recognising phospho-tau
|
|
WO2012055933A1
(en)
|
2010-10-26 |
2012-05-03 |
Ac Immune S.A. |
Liposome-based construct comprising a peptide modified through hydrophobic moieties
|
|
US20120321694A1
(en)
*
|
2010-10-27 |
2012-12-20 |
Daniel Larocque |
Compositions and uses
|
|
MA34828B1
(fr)
|
2011-01-10 |
2014-01-02 |
Zinfandel Pharmaceuticals Inc |
Procédés et produits médicamenteux destinés au traitement de la maladie d'alzheimer
|
|
US9499488B2
(en)
*
|
2011-07-11 |
2016-11-22 |
Beth Israel Deaconess Medical Center, Inc. |
Vitamin D receptor agonists and uses thereof
|
|
KR20160099732A
(ko)
|
2011-09-23 |
2016-08-22 |
에이씨 이뮨 에스.에이. |
백신 요법
|
|
BR112014008202B1
(pt)
|
2011-10-07 |
2022-01-04 |
Ac Immune S.A. |
Anticorpo, polinucleotídeo, composição farmacêutica, usos de um anticorpo, método in vitro, método de detecção da formação de um complexo imunológico, método de detecção postmortem de multimêros do fosfo-tau, kits de teste, linhagem celular isolada e método de detecção de multimêros de fosfo-tau
|
|
KR102132041B1
(ko)
|
2012-04-05 |
2020-07-09 |
에이씨 이뮨 에스.에이. |
인간화된 타우 항체
|
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
|
HUE032613T2
(en)
|
2012-06-04 |
2017-10-30 |
Diamedica Therapeutics Inc |
Human tissue kallikrein 1 is glycosylated isoforms
|
|
WO2014025761A1
(en)
*
|
2012-08-07 |
2014-02-13 |
Children's Medical Center Corporation |
Methods to treat neurodegenerative diseases
|
|
PE20151026A1
(es)
*
|
2012-12-13 |
2015-07-11 |
Lundbeck & Co As H |
Composiciones que comprenden vortioxetina y donepezilo
|
|
US9200068B2
(en)
*
|
2012-12-18 |
2015-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods related to tauopathy
|
|
JP6568514B2
(ja)
|
2013-03-15 |
2019-08-28 |
エーシー イミューン エス．エー． |
抗タウ抗体及び使用方法
|
|
US10662193B2
(en)
|
2014-01-21 |
2020-05-26 |
Ac Immune Sa |
Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
|
|
US10314911B2
(en)
*
|
2014-04-08 |
2019-06-11 |
Healthpartners Research & Education |
Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin
|
|
US9814712B2
(en)
*
|
2014-05-09 |
2017-11-14 |
Tecnimede Sociedade Tecnico-Medicinal S.A. |
(S)-pirlindole and its pharmaceutically acceptable salts for use in medicine
|
|
MA39448B1
(fr)
*
|
2014-05-09 |
2019-12-31 |
Tecnimede Sociedade Tecnico Medicinal S |
(r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
|
|
CN107428820B
(zh)
|
2014-11-19 |
2022-03-22 |
阿克松神经系统科学公司 |
在阿尔茨海默氏病中的人源化tau抗体
|
|
JP6793134B2
(ja)
|
2015-06-05 |
2020-12-02 |
ジェネンテック， インコーポレイテッド |
抗ｔａｕ抗体及び使用方法
|
|
MX380290B
(es)
|
2015-08-10 |
2025-03-12 |
Alzheon Inc |
Composiciones y métodos para el tratamiento y la prevención de trastornos neurodegenerativos.
|
|
EP3374379A4
(en)
|
2015-11-09 |
2019-05-15 |
The University Of British Columbia |
N-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATION-SELECTIVE ANTIBODIES
|
|
AU2016354688B2
(en)
|
2015-11-09 |
2021-12-16 |
The University Of British Columbia |
Epitopes in Amyloid beta mid-region and conformationally-selective antibodies thereto
|
|
HK1259324A1
(zh)
|
2015-11-09 |
2019-11-29 |
英属哥伦比亚大学 |
淀粉样蛋白β表位及其抗体
|
|
ITUA20161679A1
(it)
|
2016-03-15 |
2017-09-15 |
Neuraxpharm Italy S P A |
Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi
|
|
KR102550991B1
(ko)
|
2016-07-18 |
2023-07-04 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에 대한 항체
|
|
WO2018038973A1
(en)
*
|
2016-08-20 |
2018-03-01 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
MY198942A
(en)
|
2016-12-07 |
2023-10-03 |
Genentech Inc |
Anti-tau antibodies and methods of use
|
|
CN110248959B
(zh)
|
2016-12-07 |
2023-06-30 |
基因泰克公司 |
抗tau抗体和使用方法
|
|
KR20190122706A
(ko)
|
2017-03-09 |
2019-10-30 |
다이어메디카 인코포레이티드 |
조직 칼리크레인 1의 투약 형태
|
|
EP3601337A1
(en)
|
2017-03-28 |
2020-02-05 |
Genentech, Inc. |
Methods of treating neurodegenerative diseases
|
|
CA3061340A1
(en)
|
2017-04-25 |
2018-11-01 |
Temple Otorongo Llc |
Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
|
|
KR101917128B1
(ko)
|
2017-04-28 |
2018-11-09 |
강원대학교산학협력단 |
산양삼 추출물을 포함하는 알츠하이머병의 예방 또는 치료용 약학 조성물
|
|
WO2019018445A1
(en)
*
|
2017-07-17 |
2019-01-24 |
Maxwell Biosciences, Inc. |
POLYTHERAPY MODULATING THE MODULATION OF CATHELICIDINE GENE EXPRESSION FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISEASES
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
WO2019074840A1
(en)
*
|
2017-10-09 |
2019-04-18 |
Keith Black |
COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOID RELATED DISEASES
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
TWI827557B
(zh)
|
2017-10-25 |
2024-01-01 |
美商健生醫藥公司 |
Ｔａｕ胜肽之組成物及其用途
|
|
BR112020012833A2
(pt)
|
2018-01-05 |
2021-01-05 |
Ac Immune Sa. |
Derivados de 1, 3, 4, 5-tetra-hidro-2h-pirido[4,3-b]indol para o tratamento, alívio ou prevenção de distúrbios associados com agregados de tau, como doença de alzheimer
|
|
RU2020135052A
(ru)
|
2018-03-28 |
2022-04-29 |
Аксон Ньюросайенс Се |
Способы выявления и лечения болезни альцгеймера на основе антител
|
|
MX2020013115A
(es)
|
2018-06-04 |
2021-05-12 |
Ac Immune Sa |
Compuestos de tetrahidrobenzofuro[2,3-c]piridina y beta-carbolina para el tratamiento, el alivio o la prevencion de trastornos asociados con los agregados de tau.
|
|
CN112313230B
(zh)
|
2018-06-04 |
2024-03-15 |
Ac免疫有限公司 |
用于治疗、缓解或预防与Tau聚集体相关的病症的新型化合物
|
|
KR20200086198A
(ko)
|
2019-01-08 |
2020-07-16 |
주식회사 솔고 바이오메디칼 |
수소 흡장 금속을 포함하는 치매 예방 또는 치료용 조성물
|
|
US20200222400A1
(en)
*
|
2019-01-16 |
2020-07-16 |
Yumanity Therapeutics, Inc. |
Methods for the treatment of neurological disorders
|
|
EP3920966A2
(en)
|
2019-02-08 |
2021-12-15 |
AC Immune S.A. |
Method of safe administration of phosphorylated tau peptide vaccine
|
|
CN113453688A
(zh)
|
2019-03-01 |
2021-09-28 |
Ac免疫有限公司 |
用于治疗、减轻或预防与Tau聚集体相关的病症的新化合物
|
|
JP2022529353A
(ja)
|
2019-04-17 |
2022-06-21 |
コンパス パスファインダー リミテッド |
神経認知障害、慢性疼痛を治療し、炎症を低減させる方法
|
|
JP7327788B2
(ja)
*
|
2019-08-06 |
2023-08-16 |
学校法人福岡大学 |
糖化産物生成抑制剤及び医薬組成物
|
|
WO2021055670A1
(en)
|
2019-09-20 |
2021-03-25 |
Avx Corporation |
Somatic cell-based electrical biosensor
|
|
WO2021067850A2
(en)
*
|
2019-10-02 |
2021-04-08 |
Washington University |
METHODS OF DETECTING circRNA
|
|
ES2821599A1
(es)
|
2019-10-24 |
2021-04-26 |
Univ Del Pais Vasco / Euskal Herriko Unibertsitatea |
Compuestos y metodos para el tratamiento de la enfermedad de alzheimer
|
|
CN112939823A
(zh)
*
|
2019-12-10 |
2021-06-11 |
中国石油天然气股份有限公司 |
泥页岩抑制剂制备方法及抑制剂的应用
|
|
KR20210133603A
(ko)
|
2020-04-29 |
2021-11-08 |
정지영 |
굼벵이를 포함하는 치매 예방 또는 치료용 조성물
|
|
US20210353566A1
(en)
*
|
2020-05-12 |
2021-11-18 |
Massachusetts Institute Of Technology |
The use of choline supplementation as therapy for apoe4-related disorders
|
|
AR123730A1
(es)
|
2020-10-15 |
2023-01-04 |
Ac Immune Sa |
Compuestos novedosos
|
|
JP7682515B2
(ja)
*
|
2020-12-11 |
2025-05-26 |
国立研究開発法人国立長寿医療研究センター |
認知症の危険性判定システムおよび認知症の危険性判定用プログラム
|
|
KR102598904B1
(ko)
*
|
2022-12-16 |
2023-11-06 |
닥터노아바이오텍 주식회사 |
콜린에스터라제 억제제의 부작용 예방 또는 치료용 조성물
|
|
JP2024534151A
(ja)
|
2021-08-27 |
2024-09-18 |
ジェネンテック， インコーポレイテッド |
タウ病態の治療方法
|
|
CN115624555A
(zh)
*
|
2022-02-24 |
2023-01-20 |
中国药科大学 |
猪去氧胆酸在制备抗抑郁药物中的应用
|
|
KR20240162497A
(ko)
|
2022-03-14 |
2024-11-15 |
제넨테크, 인크. |
음성 분석에 기반한 신경퇴행성 질환 예측
|
|
KR20230147988A
(ko)
*
|
2022-04-15 |
2023-10-24 |
아주대학교산학협력단 |
Rage 길항제 및 age 소거제를 포함하는 당뇨성 뇌졸중 예방 또는 치료용 약학적 조성물
|
|
CN119404251A
(zh)
|
2022-06-21 |
2025-02-07 |
基因泰克公司 |
基于言语分析检测阿尔茨海默病(ad)的纵向进展
|
|
CN119570766B
(zh)
*
|
2025-02-08 |
2025-05-16 |
上海锴泰生物科技有限公司 |
一种胶原蛋白酶突变体、基因片段、重组质粒、重组表达体系、胶原蛋白肽，及其制备方法和用途
|